Stocks & ETFs Screener: 200+ results (Biotechnology)

Symbol	Industry	Market Cap	Fund. Score	Div. Score	Tech. Score	P/E	Return 12m vs S&P 500
ABBV AbbVie	Biotechnology Biologics, Immunology, Oncology	406B	50.7%	68.6%	86.9%	175	18.4%
AMGN Amgen	Biotechnology Rheumatoid Arthritis, Psoriasis	181B	82.4%	67.9%	52.9%	26.0	3.65%
GILD Gilead Sciences	Biotechnology Antivirals, Oncology, Hepatitis	155B	83.5%	65.5%	87.3%	19.4	25.9%
VRTX Vertex	Biotechnology Cystic Fibrosis, Sickle Cell, Beta	109B	87.4%	-	19.4%	30.0	-18.9%
REGN Regeneron	Biotechnology Eylea, Dupixent, Libtayo	78.1B	79.4%	14.9%	-6.60%	17.7	-9.82%
ALNY Alnylam	Biotechnology RNAi Therapeutics, Patisiran	60.0B	60.3%	-	87.1%	-	52.7%
ARGX argenx	Biotechnology Antibody,Autoimmune,Therapy,FcRn,Ig..	57.2B	71.1%	-	80.7%	39.2	32.2%
HLN Haleon	Biotechnology Toothpaste, Vitamins, Pain-Relief	44.0B	52.5%	53.3%	49.3%	21.8	-9.25%
INSM Insmed	Biotechnology Inhaled Antibiotic, DPP1	42.4B	33.9%	-	86.6%	-	147%
ONC BeiGene	Biotechnology BTK-Inhibitor, Anti-PD-1	38.7B	63.8%	-	65.5%	659	54.3%
NTRA Natera	Biotechnology Prenatal Screening, Carrier	31.8B	47.1%	-	69.3%	-	28.1%
22UA BioNTech SE	Biotechnology Cancer Vaccines, mRNA Therapies	24.9B	21.7%	1.0%	-67.9%	-	-32.6%
BNTX BioNTech SE	Biotechnology Oncology Vaccines,Checkpoint	24.7B	17.6%	1.0%	-57.1%	-	-29.4%
BIIB Biogen	Biotechnology Multiple Sclerosis Therapies	24.6B	71.9%	-	-33.6%	15.3	-1.65%
UTHR United Therapeutics	Biotechnology Treprostinil, Treprostinil	20.1B	92.5%	-	65.7%	17.7	14.3%
INCY Incyte	Biotechnology JAKAFI, MONJUVI, PEMAZYRE	19.9B	90.1%	-	38.1%	17.2	27.6%
GMAB Genmab AS	Biotechnology Antibody, Cancer, Lymphoma	18.8B	79.1%	-	-0.91%	13.4	30.9%
BIM Biomerieux	Biotechnology Diagnostic, Instruments, Reagents	14.7B	80.4%	60.4%	32.2%	33.9	-1.41%
NBIX Neurocrine	Biotechnology Movement, Endocrine	14.4B	85.0%	-	35.9%	34.6	-1.90%
ROIV Roivant Sciences	Biotechnology Antibody, Small-Molecule, Inhaled	14.1B	29.4%	-	81.9%	-	43.8%
RVMD Revolution	Biotechnology RAS Inhibitors, Companion	13.7B	25.6%	-	58.9%	-	13.1%
EXAS EXACT Sciences	Biotechnology Colorectal, Breast, Colon	13.2B	46.3%	-	35.6%	-	61.7%
ASND Ascendis Pharma AS	Biotechnology Growth Hormone	12.9B	36.0%	-	77.8%	-	41.0%
BBIO BridgeBio Pharma	Biotechnology ATTR Medication, FGFR Inhibitor	12.5B	50.7%	-	83.1%	-	130%
SMMT Summit Therapeutics	Biotechnology Antibody, Immunotherapy, Oncology	12.3B	47.2%	-	55.7%	-	-17.9%
ERF Eurofins	Biotechnology Testing, Laboratory, Services	12.1B	70.5%	2.77%	17.8%	26.0	10.2%
IONS Ionis	Biotechnology Triglyceride, Amyloidosis, SMA	12.1B	24.3%	0.21%	69.3%	-	95.5%
MDGL Madrigal	Biotechnology Rezdiffra, Liver Therapy, MASH	12.0B	57.3%	-	82.5%	-	50.4%
EXEL Exelixis	Biotechnology Cabozantinib, Cobimetinib	11.3B	93.7%	-	79.5%	17.7	2.52%
RNA Avidity Biosciences	Biotechnology Antibody-Oligonucleotide	10.7B	31.8%	-	79.6%	-	39.3%
BMRN Biomarin	Biotechnology Enzyme replacement therapy	10.4B	85.4%	-	-67.3%	20.1	-24.7%
MRNA Moderna	Biotechnology Respiratory Vaccines, Latent	9.75B	26.0%	-	-86.0%	-	-51.2%
HALO Halozyme	Biotechnology Enzyme, Cancer, Immunodeficiency	8.26B	92.1%	-	53.5%	14.8	36.7%
ABVX Abivax American	Biotechnology Obefazimod, Immunoregulatory	8.19B	38.7%	-	75.9%	-	1,206%
ABVX Abivax	Biotechnology Drug, Phase3, Ulcerative, Crohns	8.02B	39.0%	-	68.5%	-	1,062%
CYTK Cytokinetics	Biotechnology Cardiac Activator, Skeletal	7.76B	43.3%	-	42.5%	-	18.1%
NUVL Nuvalent	Biotechnology ROS1 Inhibitor, ALK Inhibitor	7.70B	25.7%	-	63.1%	-	1.12%
GRFS Grifols	Biotechnology Immunoglobulin, Albumin	7.65B	68.0%	41.0%	16.3%	13.8	-12.8%
MRUS Merus BV	Biotechnology Bispecific Antibodies, BIZENGRI	7.28B	31.2%	-	91.9%	-	86.6%
CDTX Cidara Therapeutics	Biotechnology Antifungal, Antiviral, Oncology	6.90B	23.3%	-	77.8%	-	940%
RYTM Rhythm	Biotechnology Setmelanotide, Rare Obesity, MC4R	6.79B	43.2%	-	93.0%	-	57.0%
PCVX Vaxcyte	Biotechnology Pneumococcal, Streptococcus	6.25B	26.7%	-	-10.9%	-	-52.6%
RGC Regencell	Biotechnology Traditional Chinese Medicine	6.24B	36.4%	-	78.5%	-	6,535%
PTCT PTC Therapeutics	Biotechnology Translarna, Emflaza, Upstaza	6.07B	64.5%	-	59.8%	8.93	63.9%
KRYS Krystal Biotech	Biotechnology Gene, Therapy, Topical, Wound, Skin	5.93B	89.1%	-	61.6%	30.7	-2.50%
ARWR Arrowhead	Biotechnology Plozasiran, Olpasiran, Fazirsiran	5.59B	34.9%	-	27.9%	-	108%
PTGX Protagonist	Biotechnology Peptide, Hematology, Inflammation	5.34B	64.2%	-	89.2%	129	70.0%
COGT Cogent Biosciences	Biotechnology Kinase Inhibitor, FGFR Inhibitor	5.33B	47.8%	-	64.8%	-	270%
ACLX Arcellx	Biotechnology Anitocabtagene Autoleucel	5.24B	32.4%	-	63.1%	-	-26.0%
LEGN Legend Biotech	Biotechnology CAR-T, Oncology, Myeloma	5.20B	32.0%	-	-50.4%	-	-43.9%
TGTX TG Therapeutics	Biotechnology Anti-CD20 Antibody, BTK Inhibitor	4.92B	66.2%	-	37.6%	11.2	-18.3%
ALKS Alkermes	Biotechnology Schizophrenia, Bipolar, Alcohol	4.83B	86.5%	-	9.08%	14.6	-15.2%
CRSP Crispr Therapeutics	Biotechnology Gene-Edited Cell Therapy, CAR T	4.79B	27.1%	-	7.28%	-	-10.2%
KYMR Kymera Therapeutics	Biotechnology IRAK4, STAT6, TYK2, Protein	4.65B	27.4%	-	58.8%	-	23.1%
APGE Apogee	Biotechnology Monoclonal Antibody, Atopic	4.53B	35.0%	-	61.0%	-	36.6%
CELC Celcuity	Biotechnology Cancer Test, Therapy Candidate	4.36B	24.3%	-	77.8%	-	542%
NAMS NewAmsterdam	Biotechnology Obicetrapib, Ezetimibe, CETP	4.34B	33.6%	-	82.0%	-	64.9%
VKTX Viking Therapeutics	Biotechnology VK2809, VK2735, VK5211, VK0214	4.27B	39.5%	-	42.2%	-	-41.2%
PRAX Praxis Precision	Biotechnology Ulixacaltamide, Vormatrigine	4.25B	27.9%	-	46.5%	-	126%
BLTE Belite Bio	Biotechnology Oral Therapy, Stargardt	4.21B	32.9%	-	85.4%	-	59.4%
IMVT Immunovant	Biotechnology Monoclonal Antibodies, Autoimmune	4.16B	25.3%	-	18.7%	-	-23.4%
ADMA ADMA Biologics	Biotechnology IVIG, Immune Globulin, Hepatitis	4.10B	84.7%	-	40.1%	20.0	-24.7%
CRNX Crinetics	Biotechnology Paltusotine, Atumelnant, CRN09682	4.07B	22.7%	-	38.8%	-	-31.0%
INDV Indivior Ordinary	Biotechnology Suboxone, Sublocade, Subutex, Opvee	4.03B	74.7%	2.63%	60.6%	32.9	167%
CNTA Centessa	Biotechnology Sleep Disorder Drug	4.02B	30.3%	-	70.9%	-	51.6%
ACAD ACADIA	Biotechnology Parkinsons Psychosis Drug, Rett	3.99B	85.9%	-	53.0%	15.2	27.6%
LGND Ligand	Biotechnology Infectious, Oncology, Nephrology	3.92B	55.6%	0.14%	82.2%	87.7	51.4%
SRRK Scholar Rock	Biotechnology Monoclonal Antibodies, Inhibitor	3.88B	22.8%	-	35.0%	-	-2.20%
GRAL GRAIL	Biotechnology Cancer Screening, Diagnostic Aid	3.65B	40.1%	-	91.5%	-	456%
ARQT Arcutis	Biotechnology Topical Cream, Topical Foam, JAK1	3.61B	41.6%	-	50.6%	-	152%
MIRM Mirum	Biotechnology LIVMARLI, Cholbam, Chenodal	3.55B	48.4%	-	91.9%	-	44.0%
IRON Disc Medicine	Biotechnology Porphyria Drug, Anemia Drug	3.50B	33.0%	-	44.4%	-	28.8%
VCYT Veracyte	Biotechnology Thyroid, Prostate, Bladder	3.48B	63.5%	-	23.7%	116	0.31%
CGON CG Oncology	Biotechnology Oncolytic Immunotherapy	3.42B	32.2%	-	22.5%	-	13.3%
MLYS Mineralys	Biotechnology Phase II Inhibitor, Oral	3.31B	30.8%	-	74.0%	-	196%
RARE Ultragenyx	Biotechnology Biologic, Gene Therapy, Antibody	3.24B	36.4%	-	-50.7%	-	-38.6%
XENE Xenon	Biotechnology Kv7 Opener, Phase 3, Epilepsy	3.18B	33.1%	-	18.7%	-	-10.9%
KNSA Kiniksa	Biotechnology ARCALYST, Vixarelimab, KPL-387	3.13B	68.5%	-	92.9%	91.7	70.0%
TVTX Travere	Biotechnology Medication, Tablets, Enzyme	3.11B	29.2%	-	40.9%	-	73.8%
FOLD Amicus Therapeutics	Biotechnology Galafold, Pombiliti, Opfolda, Gene	2.95B	52.4%	-	-26.2%	-	-10.2%
DYN Dyne Therapeutics	Biotechnology Therapeutics, Muscular Dystrophy	2.94B	28.5%	-	21.1%	-	-35.0%
IDYA Ideaya Biosciences	Biotechnology Oncology, Kinase, Inhibitor, ADC	2.90B	24.9%	-	58.6%	-	15.3%
CPRX Catalyst	Biotechnology Firdapse, Fycompa, Ruzurgi, Agamree	2.86B	91.0%	-	27.0%	13.6	-2.06%
VRDN Viridian	Biotechnology Monoclonal Antibody, Thyroid Eye	2.77B	50.3%	-	34.7%	-	34.5%
DNLI Denali Therapeutics	Biotechnology RIPK1 Inhibitor, LRRK2 Inhibitor	2.56B	25.5%	-	-58.6%	-	-31.8%
AGIO Agios Pharm	Biotechnology Mitapivat, Tebapivat, AG-181	2.55B	35.9%	-	-7.34%	-	-59.3%
APLS Apellis	Biotechnology Therapeutic, Complement	2.48B	76.5%	-	-63.9%	54.5	-44.3%
RCUS Arcus Biosciences	Biotechnology HIF-2a-Inhibitor	2.47B	34.0%	-	-16.9%	-	40.5%
SLNO Soleno Therapeutics	Biotechnology Diazoxide, Choline, Tablet, Rare	2.42B	41.6%	-	60.0%	-	-29.2%
EWTX Edgewise	Biotechnology Muscle Disorder Therapies	2.40B	30.4%	-	12.3%	-	-35.2%
NUVB Nuvation Bio	Biotechnology Oncology Pipeline Drug Candidates	2.40B	34.1%	-	60.3%	-	126%
NNNN Anbio	Biotechnology Antigen Tests, Immunoassay	2.32B	66.8%	-	85.3%	858	280%
BEAM Beam Therapeutics	Biotechnology Base-Editing Therapeutics, Sickle	2.25B	26.2%	-	-57.9%	-	-21.8%
ZLAB Zai Lab	Biotechnology Oncology, Immunology	2.22B	29.7%	-	-45.2%	-	-37.4%
RXRX Recursion	Biotechnology Drug Discovery Platform	2.17B	26.5%	-	-69.7%	-	-36.3%
GPCR Structure	Biotechnology GSBR-1290, ACCG-2671, ANPA-0073	2.08B	30.2%	-	27.2%	-	-8.37%
IBRX Immunitybio	Biotechnology Immunotherapy, Vaccine, Cytokine	2.05B	66.8%	-	-73.8%	-	-62.3%
AUPH Aurinia	Biotechnology Immunosuppressant, Lupus	2.02B	94.3%	-	61.3%	27.4	63.3%
GLPG Galapagos	Biotechnology Medicine, Oncology, Immunology	2.02B	39.3%	-	0.46%	-	0.37%
GLPG Galapagos	Biotechnology CAR-T, Oncology, Immunology	2.01B	27.3%	-	-13.4%	-	-9.08%
VCEL Vericel Ord	Biotechnology Cartilage, Skin, Burn, Autologous	2.00B	60.3%	-	-0.34%	152	-41.5%
IMCR Immunocore Holdings	Biotechnology Oncology Immunotherapy	1.99B	43.2%	-	-0.27%	-	4.16%
SION Sionna	Biotechnology Galicaftor, Navocaftor, SION-109	1.95B	37.1%	-	91.0%	-	122%
MESO Mesoblast	Biotechnology Stem-Cell Therapy, Inflammation	1.94B	31.7%	-	39.4%	-	25.0%
ZBIO Zenas BioPharma	Biotechnology Bifunctional Monoclonal Antibody	1.91B	31.4%	-	84.9%	2.61	199%
QURE Uniqure	Biotechnology Gene Therapy, Hemophilia Treatment	1.89B	35.4%	-	20.9%	-	309%
SYRE Spyre Therapeutics	Biotechnology Monoclonal Antibodies	1.88B	30.4%	-	-22.2%	-	-14.4%
SRPT Sarepta	Biotechnology RNA Therapeutics, Duchenne	1.83B	29.0%	-	-77.1%	-	-85.4%
OLMA Olema	Biotechnology Palazestrant, OP-3136, KAT6	1.82B	32.7%	-	58.8%	-	148%
VERA Vera Therapeutics	Biotechnology Atacicept, Mab, Dual-Inhibitor	1.82B	22.9%	3.50%	14.4%	-	-45.4%
ZYME Zymeworks Common	Biotechnology Zanidatamab, Bispecific Antibody	1.80B	22.3%	-	65.8%	-	55.4%
DNTH Dianthus	Biotechnology Monoclonal Antibody, DNTH103	1.78B	29.0%	-	46.4%	-	64.4%
JANX Janux Therapeutics	Biotechnology JANX007, JANX008, TRACTr, TRACIr	1.73B	28.2%	-	6.48%	-	-43.0%
CLDX Celldex	Biotechnology Monoclonal Antibody, Bispecific	1.72B	37.7%	-	-20.4%	-	-17.4%
ALVO Alvotech	Biotechnology Biosimilar, Autoimmune, Oncology	1.72B	38.4%	-	-42.1%	24.0	-59.8%
PHVS Pharvaris BV	Biotechnology Bradykinin, Antagonist	1.61B	28.7%	-	67.3%	-	-5.39%
IMNM Immunome	Biotechnology Antibody, Oncology, Bispecific	1.61B	41.4%	-	61.2%	-	47.7%
STOK Stoke Therapeutics	Biotechnology STK-002,Zorevunersen,ASOs,TANGO,Gen..	1.60B	73.2%	-	65.7%	41.1	127%
TWST Twist Bioscience	Biotechnology Synthetic DNA, Gene Fragments	1.59B	35.2%	-	-33.3%	-	-44.2%
MNKD MannKind	Biotechnology Inhaled Insulin, Insulin Delivery	1.56B	64.2%	-	-6.25%	50.7	-32.6%
SNDX Syndax	Biotechnology Menin Inhibitor, CSF-1R Antibody	1.52B	40.0%	-	-6.40%	-	4.27%
BCRX BioCryst	Biotechnology Antiviral Injection, Oral HAE	1.47B	72.4%	-	-41.8%	-	-17.1%
MEDCL Medincell	Biotechnology Schizophrenia, Postoperative Pain	1.46B	54.7%	-	80.7%	-	40.3%
ARDX Ardelyx	Biotechnology IBS-C Therapy, Phosphate	1.42B	30.0%	-	44.3%	-	-7.52%
ATAI ATAI Life Sciences	Biotechnology Psychedelic, Intranasal, Oral	1.38B	37.1%	-	35.7%	-	102%
PGEN Precigen	Biotechnology UltraCAR-T, AdenoVerse, PRGN-3005	1.36B	37.7%	-	57.1%	-	263%
TNGX Tango Therapeutics	Biotechnology PRMT5 Inhibitor, Glioblastoma	1.35B	32.7%	-	40.5%	-	140%
ORKA Oruka Therapeutics	Biotechnology Monoclonal Antibody	1.33B	29.6%	1.0%	48.7%	-	42.5%
BTX BlackRock	Biotechnology Technology, Private, Equity	1.32B	34.8%	87.9%	14.0%	51.8	-17.1%
DVAX Dynavax	Biotechnology Hepatitis Vaccine, Adjuvant	1.31B	45.5%	-	-24.8%	-	-19.1%
BHVN Biohaven	Biotechnology Troriluzole, Taldefgrobep	1.29B	36.5%	-	-57.8%	-	-81.1%
NRIX Nurix Therapeutics	Biotechnology BTK Degrader, IRAK4 Degrader	1.29B	30.8%	-	-15.5%	-	-30.6%
UPB Upstream Bio	Biotechnology Verekitug, Asthma, Rhinosinusitis	1.26B	38.0%	-	56.8%	-	23.0%
IMTX Immatics	Biotechnology TCR-Engineered Cell Therapy, TCR	1.24B	23.7%	-	16.1%	-	23.3%
MBX MBX Biosciences	Biotechnology Hypoparathyroidism, Hypoglycemia	1.22B	31.8%	-	59.1%	3.53	42.2%
RLAY Relay Therapeutics	Biotechnology PI3Ka Inhibitor, Estrogen	1.17B	46.9%	-	-28.6%	-	48.4%
URGN UroGen Pharma	Biotechnology Jelmyto, UGN-102, UGN-103	1.16B	46.5%	-	68.0%	-	90.5%
TSHA Taysha Gene	Biotechnology Gene, Therapy, AAV, CNS, Monogenic	1.15B	36.4%	-	52.9%	-	35.0%
XNCR Xencor	Biotechnology Engineered Monoclonal Antibodies	1.13B	18.3%	-	-63.1%	-	-43.3%
CVAC CureVac	Biotechnology MRNA Vaccines, Oncology Therapies	1.13B	85.0%	-	3.36%	5.08	62.9%
ORIC Oric	Biotechnology ORIC-114, ORIC-944, ORIC-533	1.13B	33.0%	-	58.5%	-	5.45%
PHARM Pharming	Biotechnology RUCONEST, Joenja, OTL-105	1.12B	69.7%	-	49.2%	-	77.8%
PVLA Palvella	Biotechnology Topical Rapamycin Gel, Microcystic	1.11B	24.8%	-	34.9%	-	414%
OCS Oculis Holding	Biotechnology OCS-01, OCS-02, OCS-05	1.11B	29.4%	-	60.4%	-	15.1%
ANAB AnaptysBio	Biotechnology Antibody, Autoimmune	1.11B	24.6%	-	48.7%	-	53.7%
CSTL Castle Biosciences	Biotechnology Melanoma, Squamous, Uveal	1.11B	53.5%	-	28.2%	-	15.1%
MDXG MiMedx	Biotechnology Placental Allografts, Wound Care	1.10B	83.7%	-	13.7%	27.3	-34.2%
MNMD Mind Medicine	Biotechnology MM120, MM402, Anxiety, ADHD, Autism	1.06B	29.0%	-	67.4%	-	36.3%
NVAX Novavax	Biotechnology Vaccine, Adjuvant, Nanoparticle	1.05B	40.5%	-	-53.2%	3.22	-37.2%
ABCL Abcellera Biologics	Biotechnology Antibody, Metabolic, Autoimmune	1.05B	19.3%	-	-23.5%	-	6.83%
OPK Opko Health	Biotechnology Diagnostics, Laboratory-Testing	1.05B	20.6%	-	-38.3%	-	-29.2%
KOD Kodiak Sciences	Biotechnology Anti-VEGF, Biopolymer Conjugate	1.04B	44.4%	-	47.4%	-	200%
NBTX Nanobiotix	Biotechnology Nanoparticles, Radiotherapy	1.01B	45.8%	-	76.2%	-	455%
NANO Nanobiotix S.A	Biotechnology Nanoparticle, Radiotherapy	1.01B	41.7%	-	74.8%	-	399%
SVRA Savara	Biotechnology Molgramostim, Proteinosis	1.00B	21.8%	-	71.5%	-	34.9%
BCAX Bicara	Biotechnology Ficerafusp Alfa, Bifunctional	988M	29.8%	-	-1.24%	3.35	-8.67%
KURA Kura Oncology	Biotechnology Menin Inhibitor, Farnesyl	975M	54.0%	-	-19.8%	-	-5.52%
NTLA Intellia	Biotechnology In-Vivo CRISPR, CAR-T, NK Cell	951M	34.1%	-	-64.2%	-	-50.2%
GLUE Monte Rosa	Biotechnology MRT-2359, MRT-6160, MRT-8102, CDK2	926M	71.5%	-	27.5%	44.4	64.5%
RZLT Rezolute	Biotechnology Antibody, Hyperinsulinism	912M	35.0%	-	71.1%	-	77.5%
MLTX MoonLake	Biotechnology Nanobody, IL-17A, IL-17F	905M	25.8%	-	8.10%	-	-78.6%
IOVA Iovance	Biotechnology Amtagvi, Proleukin, Lifileucel	889M	42.7%	-	-79.3%	-	-76.2%
SANA Sana Biotechnology	Biotechnology Allogeneic Islet Therapy, CAR-T	876M	33.9%	-	2.07%	-	26.0%
DAWN Day One	Biotechnology Tovorafenib, DAY301, VRK1 Inhibitor	875M	31.3%	-	-69.9%	-	-41.6%
GHRS GH Research	Biotechnology Mebufotenin, Depression	869M	27.0%	-	38.4%	-	41.3%
LENZ LENZ Therapeutics	Biotechnology Ophthalmic, Presbyopia, Clinical	867M	39.4%	1.0%	26.2%	-	-21.4%
CMPX Compass	Biotechnology Tovecimig, CTX-471, CTX-8371	866M	28.3%	-	34.2%	-	191%
AVBP ArriVent	Biotechnology Firmonertinib, ARR-217, ARR-002	840M	40.1%	-	-12.0%	-	-31.0%
TYRA Tyra Biosciences	Biotechnology Precision Medicine Platform, FGFR	840M	28.3%	-	50.6%	-	21.5%
RIGL Rigel	Biotechnology Kinase, Inhibitor	839M	92.0%	-	67.9%	7.47	68.5%
ABUS Arbutus Biopharma	Biotechnology RNAi Therapeutic, PD-L1 Inhibitor	829M	29.9%	-	57.9%	-	10.2%
ERAS Erasca	Biotechnology Naporafenib, ERAS-0015, ERAS-4001	828M	34.5%	-	-42.8%	-	-7.56%
CDNA CareDx	Biotechnology AlloSure, AlloMap, AlloSeq	820M	52.7%	-	-21.3%	12.5	-34.2%
IVA Inventiva S.A	Biotechnology Lanifibranor, Odiparcil, TGF-Beta	794M	43.3%	-	10.4%	-	26.9%
VIR Vir Biotechnology	Biotechnology HDV, RSV, HPV, Coronavirus, TCE	783M	29.9%	-	-78.1%	-	-27.4%
ALMS Alumis	Biotechnology TYK2 Inhibitor, Psoriasis, Lupus	762M	50.9%	-	-76.5%	-	-31.6%
RAPT RAPT Therapeutics	Biotechnology CCR4 Antagonist, Inflammation	750M	29.2%	-	-23.7%	-	187%
SPRY ARS	Biotechnology Epinephrine, Nasal Spray	750M	27.6%	-	-1.55%	-	-48.3%
VLA Valneva SE	Biotechnology Japanese Encephalitis, Cholera	745M	21.5%	-	-4.98%	-	66.5%
ESPR Esperion	Biotechnology Cholesterol-Lowering Tablets	730M	53.5%	-	-26.9%	-	8.89%
REPL Replimune	Biotechnology Oncolytic Immunotherapy, RP1, RP2	722M	28.0%	-	-74.0%	-	-37.5%
GERN Geron	Biotechnology Telomerase Inhibitor	715M	28.8%	-	-65.9%	-	-75.0%
ATXS Astria Therapeutics	Biotechnology Monoclonal, Antibody, Plasma	711M	33.9%	-	13.1%	-	9.02%
ORGO Organogenesis	Biotechnology Wound Care, Surgical Matrix	709M	32.9%	-	45.6%	-	17.8%
GOSS Gossamer Bio	Biotechnology Seralutinib, GB002, PAH Therapy	708M	34.5%	-	-4.67%	-	301%
LXEO Lexeo	Biotechnology Gene Therapy, Cardiomyopathy	692M	34.7%	-	-1.87%	-	22.0%
KALV Kalvista	Biotechnology Plasma Kallikrein Inhibitors, Oral	688M	37.6%	-	61.5%	-	17.1%
CRVS Corvus	Biotechnology Kinase Inhibitor, Adenosine	665M	32.1%	-	55.7%	-	-15.2%
CTMX CytomX Therapeutics	Biotechnology Antibody-Drug Conjugate, T-Cell	657M	56.5%	-	51.7%	12.9	265%
ANNX Annexon	Biotechnology Antibody, Fragment	636M	34.3%	-	-32.7%	-	-21.9%
PROK ProKidney	Biotechnology Cell Therapy, Renal Cells	629M	42.7%	-	-26.3%	-	3.23%
FDMT 4D Molecular	Biotechnology Ophthalmology, Cystic-Fibrosis	619M	25.1%	-	-19.7%	-	26.2%
VSTM Verastem	Biotechnology Avutometinib, Defactinib	611M	39.6%	-	47.6%	-	122%
PRME Prime Medicine	Biotechnology Gene Editing, Prime Editing	608M	40.5%	-	-29.6%	-	0.47%
MGTX MeiraGTx Holdings	Biotechnology Gene Therapies, Retinal Diseases	600M	40.1%	-	26.9%	-	5.57%
MYGN Myriad Genetics	Biotechnology Hereditary Cancer, Companion	600M	35.5%	0.08%	-76.7%	-	-56.6%
RGNX Regenxbio	Biotechnology Gene,Therapy,AAV,Platform,Pipeline	597M	22.3%	-	-18.1%	-	12.7%
IVVD Invivyd	Biotechnology Antibody, Monoclonal, Covid	583M	39.6%	-	21.3%	-	216%
ASMB Assembly	Biotechnology Antiviral, Small-Molecule	575M	34.4%	-	57.1%	-	126%
PRTA Prothena	Biotechnology Neurodegeneration, Antibody	564M	25.4%	-	-73.2%	-	-39.1%

ABBV
AbbVie

Biotechnology
Biologics, Immunology, Oncology

406B

50.7%

68.6%

86.9%

175

18.4%

AMGN
Amgen

Biotechnology
Rheumatoid Arthritis, Psoriasis

181B

82.4%

67.9%

52.9%

26.0

3.65%

GILD
Gilead Sciences

Biotechnology
Antivirals, Oncology, Hepatitis

155B

83.5%

65.5%

87.3%

19.4

25.9%

VRTX
Vertex

Biotechnology
Cystic Fibrosis, Sickle Cell, Beta

109B

87.4%

-

19.4%

30.0

-18.9%

REGN
Regeneron

Biotechnology
Eylea, Dupixent, Libtayo

78.1B

79.4%

14.9%

-6.60%

17.7

-9.82%

ALNY
Alnylam

Biotechnology
RNAi Therapeutics, Patisiran

60.0B

60.3%

-

87.1%

-

52.7%

ARGX
argenx

Biotechnology
Antibody,Autoimmune,Therapy,FcRn,Ig..

57.2B

71.1%

-

80.7%

39.2

32.2%

HLN
Haleon

Biotechnology
Toothpaste, Vitamins, Pain-Relief

44.0B

52.5%

53.3%

49.3%

21.8

-9.25%

INSM
Insmed

Biotechnology
Inhaled Antibiotic, DPP1

42.4B

33.9%

-

86.6%

-

147%

ONC
BeiGene

Biotechnology
BTK-Inhibitor, Anti-PD-1

38.7B

63.8%

-

65.5%

659

54.3%

NTRA
Natera

Biotechnology
Prenatal Screening, Carrier

31.8B

47.1%

-

69.3%

-

28.1%

22UA
BioNTech SE

Biotechnology
Cancer Vaccines, mRNA Therapies

24.9B

21.7%

1.0%

-67.9%

-

-32.6%

BNTX
BioNTech SE

Biotechnology
Oncology Vaccines,Checkpoint

24.7B

17.6%

1.0%

-57.1%

-

-29.4%

BIIB
Biogen

Biotechnology
Multiple Sclerosis Therapies

24.6B

71.9%

-

-33.6%

15.3

-1.65%

UTHR
United Therapeutics

Biotechnology
Treprostinil, Treprostinil

20.1B

92.5%

-

65.7%

17.7

14.3%

INCY
Incyte

Biotechnology
JAKAFI, MONJUVI, PEMAZYRE

19.9B

90.1%

-

38.1%

17.2

27.6%

GMAB
Genmab AS

Biotechnology
Antibody, Cancer, Lymphoma

18.8B

79.1%

-

-0.91%

13.4

30.9%

BIM
Biomerieux

Biotechnology
Diagnostic, Instruments, Reagents

14.7B

80.4%

60.4%

32.2%

33.9

-1.41%

NBIX
Neurocrine

Biotechnology
Movement, Endocrine

14.4B

85.0%

-

35.9%

34.6

-1.90%

ROIV
Roivant Sciences

Biotechnology
Antibody, Small-Molecule, Inhaled

14.1B

29.4%

-

81.9%

-

43.8%

RVMD
Revolution

Biotechnology
RAS Inhibitors, Companion

13.7B

25.6%

-

58.9%

-

13.1%

EXAS
EXACT Sciences

Biotechnology
Colorectal, Breast, Colon

13.2B

46.3%

-

35.6%

-

61.7%

ASND
Ascendis Pharma AS

Biotechnology
Growth Hormone

12.9B

36.0%

-

77.8%

-

41.0%

BBIO
BridgeBio Pharma

Biotechnology
ATTR Medication, FGFR Inhibitor

12.5B

50.7%

-

83.1%

-

130%

SMMT
Summit Therapeutics

Biotechnology
Antibody, Immunotherapy, Oncology

12.3B

47.2%

-

55.7%

-

-17.9%

ERF
Eurofins

Biotechnology
Testing, Laboratory, Services

12.1B

70.5%

2.77%

17.8%

26.0

10.2%

IONS
Ionis

Biotechnology
Triglyceride, Amyloidosis, SMA

12.1B

24.3%

0.21%

69.3%

-

95.5%

MDGL
Madrigal

Biotechnology
Rezdiffra, Liver Therapy, MASH

12.0B

57.3%

-

82.5%

-

50.4%

EXEL
Exelixis

Biotechnology
Cabozantinib, Cobimetinib

11.3B

93.7%

-

79.5%

17.7

2.52%

RNA
Avidity Biosciences

Biotechnology
Antibody-Oligonucleotide

10.7B

31.8%

-

79.6%

-

39.3%

BMRN
Biomarin

Biotechnology
Enzyme replacement therapy

10.4B

85.4%

-

-67.3%

20.1

-24.7%

MRNA
Moderna

Biotechnology
Respiratory Vaccines, Latent

9.75B

26.0%

-

-86.0%

-

-51.2%

HALO
Halozyme

Biotechnology
Enzyme, Cancer, Immunodeficiency

8.26B

92.1%

-

53.5%

14.8

36.7%

ABVX
Abivax American

Biotechnology
Obefazimod, Immunoregulatory

8.19B

38.7%

-

75.9%

-

1,206%

ABVX
Abivax

Biotechnology
Drug, Phase3, Ulcerative, Crohns

8.02B

39.0%

-

68.5%

-

1,062%

CYTK
Cytokinetics

Biotechnology
Cardiac Activator, Skeletal

7.76B

43.3%

-

42.5%

-

18.1%

NUVL
Nuvalent

Biotechnology
ROS1 Inhibitor, ALK Inhibitor

7.70B

25.7%

-

63.1%

-

1.12%

GRFS
Grifols

Biotechnology
Immunoglobulin, Albumin

7.65B

68.0%

41.0%

16.3%

13.8

-12.8%

MRUS
Merus BV

Biotechnology
Bispecific Antibodies, BIZENGRI

7.28B

31.2%

-

91.9%

-

86.6%

CDTX
Cidara Therapeutics

Biotechnology
Antifungal, Antiviral, Oncology

6.90B

23.3%

-

77.8%

-

940%

RYTM
Rhythm

Biotechnology
Setmelanotide, Rare Obesity, MC4R

6.79B

43.2%

-

93.0%

-

57.0%

PCVX
Vaxcyte

Biotechnology
Pneumococcal, Streptococcus

6.25B

26.7%

-

-10.9%

-

-52.6%

RGC
Regencell

Biotechnology
Traditional Chinese Medicine

6.24B

36.4%

-

78.5%

-

6,535%

PTCT
PTC Therapeutics

Biotechnology
Translarna, Emflaza, Upstaza

6.07B

64.5%

-

59.8%

8.93

63.9%

KRYS
Krystal Biotech

Biotechnology
Gene, Therapy, Topical, Wound, Skin

5.93B

89.1%

-

61.6%

30.7

-2.50%

ARWR
Arrowhead

Biotechnology
Plozasiran, Olpasiran, Fazirsiran

5.59B

34.9%

-

27.9%

-

108%

PTGX
Protagonist

Biotechnology
Peptide, Hematology, Inflammation

5.34B

64.2%

-

89.2%

129

70.0%

COGT
Cogent Biosciences

Biotechnology
Kinase Inhibitor, FGFR Inhibitor

5.33B

47.8%

-

64.8%

-

270%

ACLX
Arcellx

Biotechnology
Anitocabtagene Autoleucel

5.24B

32.4%

-

63.1%

-

-26.0%

LEGN
Legend Biotech

Biotechnology
CAR-T, Oncology, Myeloma

5.20B

32.0%

-

-50.4%

-

-43.9%

TGTX
TG Therapeutics

Biotechnology
Anti-CD20 Antibody, BTK Inhibitor

4.92B

66.2%

-

37.6%

11.2

-18.3%

ALKS
Alkermes

Biotechnology
Schizophrenia, Bipolar, Alcohol

4.83B

86.5%

-

9.08%

14.6

-15.2%

CRSP
Crispr Therapeutics

Biotechnology
Gene-Edited Cell Therapy, CAR T

4.79B

27.1%

-

7.28%

-

-10.2%

KYMR
Kymera Therapeutics

Biotechnology
IRAK4, STAT6, TYK2, Protein

4.65B

27.4%

-

58.8%

-

23.1%

APGE
Apogee

Biotechnology
Monoclonal Antibody, Atopic

4.53B

35.0%

-

61.0%

-

36.6%

CELC
Celcuity

Biotechnology
Cancer Test, Therapy Candidate

4.36B

24.3%

-

77.8%

-

542%

NAMS
NewAmsterdam

Biotechnology
Obicetrapib, Ezetimibe, CETP

4.34B

33.6%

-

82.0%

-

64.9%

VKTX
Viking Therapeutics

Biotechnology
VK2809, VK2735, VK5211, VK0214

4.27B

39.5%

-

42.2%

-

-41.2%

PRAX
Praxis Precision

Biotechnology
Ulixacaltamide, Vormatrigine

4.25B

27.9%

-

46.5%

-

126%

BLTE
Belite Bio

Biotechnology
Oral Therapy, Stargardt

4.21B

32.9%

-

85.4%

-

59.4%

IMVT
Immunovant

Biotechnology
Monoclonal Antibodies, Autoimmune

4.16B

25.3%

-

18.7%

-

-23.4%

ADMA
ADMA Biologics

Biotechnology
IVIG, Immune Globulin, Hepatitis

4.10B

84.7%

-

40.1%

20.0

-24.7%

CRNX
Crinetics

Biotechnology
Paltusotine, Atumelnant, CRN09682

4.07B

22.7%

-

38.8%

-

-31.0%

INDV
Indivior Ordinary

Biotechnology
Suboxone, Sublocade, Subutex, Opvee

4.03B

74.7%

2.63%

60.6%

32.9

167%

CNTA
Centessa

Biotechnology
Sleep Disorder Drug

4.02B

30.3%

-

70.9%

-

51.6%

ACAD
ACADIA

Biotechnology
Parkinsons Psychosis Drug, Rett

3.99B

85.9%

-

53.0%

15.2

27.6%

LGND
Ligand

Biotechnology
Infectious, Oncology, Nephrology

3.92B

55.6%

0.14%

82.2%

87.7

51.4%

SRRK
Scholar Rock

Biotechnology
Monoclonal Antibodies, Inhibitor

3.88B

22.8%

-

35.0%

-

-2.20%

GRAL
GRAIL

Biotechnology
Cancer Screening, Diagnostic Aid

3.65B

40.1%

-

91.5%

-

456%

ARQT
Arcutis

Biotechnology
Topical Cream, Topical Foam, JAK1

3.61B

41.6%

-

50.6%

-

152%

MIRM
Mirum

Biotechnology
LIVMARLI, Cholbam, Chenodal

3.55B

48.4%

-

91.9%

-

44.0%

IRON
Disc Medicine

Biotechnology
Porphyria Drug, Anemia Drug

3.50B

33.0%

-

44.4%

-

28.8%

VCYT
Veracyte

Biotechnology
Thyroid, Prostate, Bladder

3.48B

63.5%

-

23.7%

116

0.31%

CGON
CG Oncology

Biotechnology
Oncolytic Immunotherapy

3.42B

32.2%

-

22.5%

-

13.3%

MLYS
Mineralys

Biotechnology
Phase II Inhibitor, Oral

3.31B

30.8%

-

74.0%

-

196%

RARE
Ultragenyx

Biotechnology
Biologic, Gene Therapy, Antibody

3.24B

36.4%

-

-50.7%

-

-38.6%

XENE
Xenon

Biotechnology
Kv7 Opener, Phase 3, Epilepsy

3.18B

33.1%

-

18.7%

-

-10.9%

KNSA
Kiniksa

Biotechnology
ARCALYST, Vixarelimab, KPL-387

3.13B

68.5%

-

92.9%

91.7

70.0%

TVTX
Travere

Biotechnology
Medication, Tablets, Enzyme

3.11B

29.2%

-

40.9%

-

73.8%

FOLD
Amicus Therapeutics

Biotechnology
Galafold, Pombiliti, Opfolda, Gene

2.95B

52.4%

-

-26.2%

-

-10.2%

DYN
Dyne Therapeutics

Biotechnology
Therapeutics, Muscular Dystrophy

2.94B

28.5%

-

21.1%

-

-35.0%

IDYA
Ideaya Biosciences

Biotechnology
Oncology, Kinase, Inhibitor, ADC

2.90B

24.9%

-

58.6%

-

15.3%

CPRX
Catalyst

Biotechnology
Firdapse, Fycompa, Ruzurgi, Agamree

2.86B

91.0%

-

27.0%

13.6

-2.06%

VRDN
Viridian

Biotechnology
Monoclonal Antibody, Thyroid Eye

2.77B

50.3%

-

34.7%

-

34.5%

DNLI
Denali Therapeutics

Biotechnology
RIPK1 Inhibitor, LRRK2 Inhibitor

2.56B

25.5%

-

-58.6%

-

-31.8%

AGIO
Agios Pharm

Biotechnology
Mitapivat, Tebapivat, AG-181

2.55B

35.9%

-

-7.34%

-

-59.3%

APLS
Apellis

Biotechnology
Therapeutic, Complement

2.48B

76.5%

-

-63.9%

54.5

-44.3%

RCUS
Arcus Biosciences

Biotechnology
HIF-2a-Inhibitor

2.47B

34.0%

-

-16.9%

-

40.5%

SLNO
Soleno Therapeutics

Biotechnology
Diazoxide, Choline, Tablet, Rare

2.42B

41.6%

-

60.0%

-

-29.2%

EWTX
Edgewise

Biotechnology
Muscle Disorder Therapies

2.40B

30.4%

-

12.3%

-

-35.2%

NUVB
Nuvation Bio

Biotechnology
Oncology Pipeline Drug Candidates

2.40B

34.1%

-

60.3%

-

126%

NNNN
Anbio

Biotechnology
Antigen Tests, Immunoassay

2.32B

66.8%

-

85.3%

858

280%

BEAM
Beam Therapeutics

Biotechnology
Base-Editing Therapeutics, Sickle

2.25B

26.2%

-

-57.9%

-

-21.8%

ZLAB
Zai Lab

Biotechnology
Oncology, Immunology

2.22B

29.7%

-

-45.2%

-

-37.4%

RXRX
Recursion

Biotechnology
Drug Discovery Platform

2.17B

26.5%

-

-69.7%

-

-36.3%

GPCR
Structure

Biotechnology
GSBR-1290, ACCG-2671, ANPA-0073

2.08B

30.2%

-

27.2%

-

-8.37%

IBRX
Immunitybio

Biotechnology
Immunotherapy, Vaccine, Cytokine

2.05B

66.8%

-

-73.8%

-

-62.3%

AUPH
Aurinia

Biotechnology
Immunosuppressant, Lupus

2.02B

94.3%

-

61.3%

27.4

63.3%

GLPG
Galapagos

Biotechnology
Medicine, Oncology, Immunology

2.02B

39.3%

-

0.46%

-

0.37%

GLPG
Galapagos

Biotechnology
CAR-T, Oncology, Immunology

2.01B

27.3%

-

-13.4%

-

-9.08%

VCEL
Vericel Ord

Biotechnology
Cartilage, Skin, Burn, Autologous

2.00B

60.3%

-

-0.34%

152

-41.5%

IMCR
Immunocore Holdings

Biotechnology
Oncology Immunotherapy

1.99B

43.2%

-

-0.27%

-

4.16%

SION
Sionna

Biotechnology
Galicaftor, Navocaftor, SION-109

1.95B

37.1%

-

91.0%

-

122%

MESO
Mesoblast

Biotechnology
Stem-Cell Therapy, Inflammation

1.94B

31.7%

-

39.4%

-

25.0%

ZBIO
Zenas BioPharma

Biotechnology
Bifunctional Monoclonal Antibody

1.91B

31.4%

-

84.9%

2.61

199%

QURE
Uniqure

Biotechnology
Gene Therapy, Hemophilia Treatment

1.89B

35.4%

-

20.9%

-

309%

SYRE
Spyre Therapeutics

Biotechnology
Monoclonal Antibodies

1.88B

30.4%

-

-22.2%

-

-14.4%

SRPT
Sarepta

Biotechnology
RNA Therapeutics, Duchenne

1.83B

29.0%

-

-77.1%

-

-85.4%

OLMA
Olema

Biotechnology
Palazestrant, OP-3136, KAT6

1.82B

32.7%

-

58.8%

-

148%

VERA
Vera Therapeutics

Biotechnology
Atacicept, Mab, Dual-Inhibitor

1.82B

22.9%

3.50%

14.4%

-

-45.4%

ZYME
Zymeworks Common

Biotechnology
Zanidatamab, Bispecific Antibody

1.80B

22.3%

-

65.8%

-

55.4%

DNTH
Dianthus

Biotechnology
Monoclonal Antibody, DNTH103

1.78B

29.0%

-

46.4%

-

64.4%

JANX
Janux Therapeutics

Biotechnology
JANX007, JANX008, TRACTr, TRACIr

1.73B

28.2%

-

6.48%

-

-43.0%

CLDX
Celldex

Biotechnology
Monoclonal Antibody, Bispecific

1.72B

37.7%

-

-20.4%

-

-17.4%

ALVO
Alvotech

Biotechnology
Biosimilar, Autoimmune, Oncology

1.72B

38.4%

-

-42.1%

24.0

-59.8%

PHVS
Pharvaris BV

Biotechnology
Bradykinin, Antagonist

1.61B

28.7%

-

67.3%

-

-5.39%

IMNM
Immunome

Biotechnology
Antibody, Oncology, Bispecific

1.61B

41.4%

-

61.2%

-

47.7%

STOK
Stoke Therapeutics

Biotechnology
STK-002,Zorevunersen,ASOs,TANGO,Gen..

1.60B

73.2%

-

65.7%

41.1

127%

TWST
Twist Bioscience

Biotechnology
Synthetic DNA, Gene Fragments

1.59B

35.2%

-

-33.3%

-

-44.2%

MNKD
MannKind

Biotechnology
Inhaled Insulin, Insulin Delivery

1.56B

64.2%

-

-6.25%

50.7

-32.6%

SNDX
Syndax

Biotechnology
Menin Inhibitor, CSF-1R Antibody

1.52B

40.0%

-

-6.40%

-

4.27%

BCRX
BioCryst

Biotechnology
Antiviral Injection, Oral HAE

1.47B

72.4%

-

-41.8%

-

-17.1%

MEDCL
Medincell

Biotechnology
Schizophrenia, Postoperative Pain

1.46B

54.7%

-

80.7%

-

40.3%

ARDX
Ardelyx

Biotechnology
IBS-C Therapy, Phosphate

1.42B

30.0%

-

44.3%

-

-7.52%

ATAI
ATAI Life Sciences

Biotechnology
Psychedelic, Intranasal, Oral

1.38B

37.1%

-

35.7%

-

102%

PGEN
Precigen

Biotechnology
UltraCAR-T, AdenoVerse, PRGN-3005

1.36B

37.7%

-

57.1%

-

263%

TNGX
Tango Therapeutics

Biotechnology
PRMT5 Inhibitor, Glioblastoma

1.35B

32.7%

-

40.5%

-

140%

ORKA
Oruka Therapeutics

Biotechnology
Monoclonal Antibody

1.33B

29.6%

1.0%

48.7%

-

42.5%

BTX
BlackRock

Biotechnology
Technology, Private, Equity

1.32B

34.8%

87.9%

14.0%

51.8

-17.1%

DVAX
Dynavax

Biotechnology
Hepatitis Vaccine, Adjuvant

1.31B

45.5%

-

-24.8%

-

-19.1%

BHVN
Biohaven

Biotechnology
Troriluzole, Taldefgrobep

1.29B

36.5%

-

-57.8%

-

-81.1%

NRIX
Nurix Therapeutics

Biotechnology
BTK Degrader, IRAK4 Degrader

1.29B

30.8%

-

-15.5%

-

-30.6%

UPB
Upstream Bio

Biotechnology
Verekitug, Asthma, Rhinosinusitis

1.26B

38.0%

-

56.8%

-

23.0%

IMTX
Immatics

Biotechnology
TCR-Engineered Cell Therapy, TCR

1.24B

23.7%

-

16.1%

-

23.3%

MBX
MBX Biosciences

Biotechnology
Hypoparathyroidism, Hypoglycemia

1.22B

31.8%

-

59.1%

3.53

42.2%

RLAY
Relay Therapeutics

Biotechnology
PI3Ka Inhibitor, Estrogen

1.17B

46.9%

-

-28.6%

-

48.4%

URGN
UroGen Pharma

Biotechnology
Jelmyto, UGN-102, UGN-103

1.16B

46.5%

-

68.0%

-

90.5%

TSHA
Taysha Gene

Biotechnology
Gene, Therapy, AAV, CNS, Monogenic

1.15B

36.4%

-

52.9%

-

35.0%

XNCR
Xencor

Biotechnology
Engineered Monoclonal Antibodies

1.13B

18.3%

-

-63.1%

-

-43.3%

CVAC
CureVac

Biotechnology
MRNA Vaccines, Oncology Therapies

1.13B

85.0%

-

3.36%

5.08

62.9%

ORIC
Oric

Biotechnology
ORIC-114, ORIC-944, ORIC-533

1.13B

33.0%

-

58.5%

-

5.45%

PHARM
Pharming

Biotechnology
RUCONEST, Joenja, OTL-105

1.12B

69.7%

-

49.2%

-

77.8%

PVLA
Palvella

Biotechnology
Topical Rapamycin Gel, Microcystic

1.11B

24.8%

-

34.9%

-

414%

OCS
Oculis Holding

Biotechnology
OCS-01, OCS-02, OCS-05

1.11B

29.4%

-

60.4%

-

15.1%

ANAB
AnaptysBio

Biotechnology
Antibody, Autoimmune

1.11B

24.6%

-

48.7%

-

53.7%

CSTL
Castle Biosciences

Biotechnology
Melanoma, Squamous, Uveal

1.11B

53.5%

-

28.2%

-

15.1%

MDXG
MiMedx

Biotechnology
Placental Allografts, Wound Care

1.10B

83.7%

-

13.7%

27.3

-34.2%

MNMD
Mind Medicine

Biotechnology
MM120, MM402, Anxiety, ADHD, Autism

1.06B

29.0%

-

67.4%

-

36.3%

NVAX
Novavax

Biotechnology
Vaccine, Adjuvant, Nanoparticle

1.05B

40.5%

-

-53.2%

3.22

-37.2%

ABCL
Abcellera Biologics

Biotechnology
Antibody, Metabolic, Autoimmune

1.05B

19.3%

-

-23.5%

-

6.83%

OPK
Opko Health

Biotechnology
Diagnostics, Laboratory-Testing

1.05B

20.6%

-

-38.3%

-

-29.2%

KOD
Kodiak Sciences

Biotechnology
Anti-VEGF, Biopolymer Conjugate

1.04B

44.4%

-

47.4%

-

200%

NBTX
Nanobiotix

Biotechnology
Nanoparticles, Radiotherapy

1.01B

45.8%

-

76.2%

-

455%

NANO
Nanobiotix S.A

Biotechnology
Nanoparticle, Radiotherapy

1.01B

41.7%

-

74.8%

-

399%

SVRA
Savara

Biotechnology
Molgramostim, Proteinosis

1.00B

21.8%

-

71.5%

-

34.9%

BCAX
Bicara

Biotechnology
Ficerafusp Alfa, Bifunctional

988M

29.8%

-

-1.24%

3.35

-8.67%

KURA
Kura Oncology

Biotechnology
Menin Inhibitor, Farnesyl

975M

54.0%

-

-19.8%

-

-5.52%

NTLA
Intellia

Biotechnology
In-Vivo CRISPR, CAR-T, NK Cell

951M

34.1%

-

-64.2%

-

-50.2%

GLUE
Monte Rosa

Biotechnology
MRT-2359, MRT-6160, MRT-8102, CDK2

926M

71.5%

-

27.5%

44.4

64.5%

RZLT
Rezolute

Biotechnology
Antibody, Hyperinsulinism

912M

35.0%

-

71.1%

-

77.5%

MLTX
MoonLake

Biotechnology
Nanobody, IL-17A, IL-17F

905M

25.8%

-

8.10%

-

-78.6%

IOVA
Iovance

Biotechnology
Amtagvi, Proleukin, Lifileucel

889M

42.7%

-

-79.3%

-

-76.2%

SANA
Sana Biotechnology

Biotechnology
Allogeneic Islet Therapy, CAR-T

876M

33.9%

-

2.07%

-

26.0%

DAWN
Day One

Biotechnology
Tovorafenib, DAY301, VRK1 Inhibitor

875M

31.3%

-

-69.9%

-

-41.6%

GHRS
GH Research

Biotechnology
Mebufotenin, Depression

869M

27.0%

-

38.4%

-

41.3%

LENZ
LENZ Therapeutics

Biotechnology
Ophthalmic, Presbyopia, Clinical

867M

39.4%

1.0%

26.2%

-

-21.4%

CMPX
Compass

Biotechnology
Tovecimig, CTX-471, CTX-8371

866M

28.3%

-

34.2%

-

191%

AVBP
ArriVent

Biotechnology
Firmonertinib, ARR-217, ARR-002

840M

40.1%

-

-12.0%

-

-31.0%

TYRA
Tyra Biosciences

Biotechnology
Precision Medicine Platform, FGFR

840M

28.3%

-

50.6%

-

21.5%

RIGL
Rigel

Biotechnology
Kinase, Inhibitor

839M

92.0%

-

67.9%

7.47

68.5%

ABUS
Arbutus Biopharma

Biotechnology
RNAi Therapeutic, PD-L1 Inhibitor

829M

29.9%

-

57.9%

-

10.2%

ERAS
Erasca

Biotechnology
Naporafenib, ERAS-0015, ERAS-4001

828M

34.5%

-

-42.8%

-

-7.56%

CDNA
CareDx

Biotechnology
AlloSure, AlloMap, AlloSeq

820M

52.7%

-

-21.3%

12.5

-34.2%

IVA
Inventiva S.A

Biotechnology
Lanifibranor, Odiparcil, TGF-Beta

794M

43.3%

-

10.4%

-

26.9%

VIR
Vir Biotechnology

Biotechnology
HDV, RSV, HPV, Coronavirus, TCE

783M

29.9%

-

-78.1%

-

-27.4%

ALMS
Alumis

Biotechnology
TYK2 Inhibitor, Psoriasis, Lupus

762M

50.9%

-

-76.5%

-

-31.6%

RAPT
RAPT Therapeutics

Biotechnology
CCR4 Antagonist, Inflammation

750M

29.2%

-

-23.7%

-

187%

SPRY
ARS

Biotechnology
Epinephrine, Nasal Spray

750M

27.6%

-

-1.55%

-

-48.3%

VLA
Valneva SE

Biotechnology
Japanese Encephalitis, Cholera

745M

21.5%

-

-4.98%

-

66.5%

ESPR
Esperion

Biotechnology
Cholesterol-Lowering Tablets

730M

53.5%

-

-26.9%

-

8.89%

REPL
Replimune

Biotechnology
Oncolytic Immunotherapy, RP1, RP2

722M

28.0%

-

-74.0%

-

-37.5%

GERN
Geron

Biotechnology
Telomerase Inhibitor

715M

28.8%

-

-65.9%

-

-75.0%

ATXS
Astria Therapeutics

Biotechnology
Monoclonal, Antibody, Plasma

711M

33.9%

-

13.1%

-

9.02%

ORGO
Organogenesis

Biotechnology
Wound Care, Surgical Matrix

709M

32.9%

-

45.6%

-

17.8%

GOSS
Gossamer Bio

Biotechnology
Seralutinib, GB002, PAH Therapy

708M

34.5%

-

-4.67%

-

301%

LXEO
Lexeo

Biotechnology
Gene Therapy, Cardiomyopathy

692M

34.7%

-

-1.87%

-

22.0%

KALV
Kalvista

Biotechnology
Plasma Kallikrein Inhibitors, Oral

688M

37.6%

-

61.5%

-

17.1%

CRVS
Corvus

Biotechnology
Kinase Inhibitor, Adenosine

665M

32.1%

-

55.7%

-

-15.2%

CTMX
CytomX Therapeutics

Biotechnology
Antibody-Drug Conjugate, T-Cell

657M

56.5%

-

51.7%

12.9

265%

ANNX
Annexon

Biotechnology
Antibody, Fragment

636M

34.3%

-

-32.7%

-

-21.9%

PROK
ProKidney

Biotechnology
Cell Therapy, Renal Cells

629M

42.7%

-

-26.3%

-

3.23%

FDMT
4D Molecular

Biotechnology
Ophthalmology, Cystic-Fibrosis

619M

25.1%

-

-19.7%

-

26.2%

VSTM
Verastem

Biotechnology
Avutometinib, Defactinib

611M

39.6%

-

47.6%

-

122%

PRME
Prime Medicine

Biotechnology
Gene Editing, Prime Editing

608M

40.5%

-

-29.6%

-

0.47%

MGTX
MeiraGTx Holdings

Biotechnology
Gene Therapies, Retinal Diseases

600M

40.1%

-

26.9%

-

5.57%

MYGN
Myriad Genetics

Biotechnology
Hereditary Cancer, Companion

600M

35.5%

0.08%

-76.7%

-

-56.6%

RGNX
Regenxbio

Biotechnology
Gene,Therapy,AAV,Platform,Pipeline

597M

22.3%

-

-18.1%

-

12.7%

IVVD
Invivyd

Biotechnology
Antibody, Monoclonal, Covid

583M

39.6%

-

21.3%

-

216%

ASMB
Assembly

Biotechnology
Antiviral, Small-Molecule

575M

34.4%

-

57.1%

-

126%

PRTA
Prothena

Biotechnology
Neurodegeneration, Antibody

564M

25.4%

-

-73.2%

-

-39.1%

Stocks & ETFs Screener: 200+ results (Biotechnology)

Basic Filter

Fundamental Filter

Benchmark

Performance/Technical